CBP/KAT3A Antibody [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NB100-381F
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Chromatin Immunoprecipitation (ChIP), Immunoprecipitation, Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for CBP/KAT3A Antibody [FITC]
Immunogen
The immunogen recognized by this antibody maps to a region between residues 975 and 1025 of human CREB Binding Protein using the numbering given in entry NP_004371.1 (GeneID 1387).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for CBP/KAT3A Antibody [FITC]
Application
Recommended Usage
Chromatin Immunoprecipitation (ChIP)
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: CBP
Long Name
CREB-binding Protein
Alternate Names
CREBBP, RTS
Gene Symbol
CREBBP
Additional CBP Products
Product Documents for CBP/KAT3A Antibody [FITC]
Product Specific Notices for CBP/KAT3A Antibody [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...